EU regulators start review of China's Sinovac vaccine
Posted May 04, 2021 7:00 am
THE HAGUE, Netherlands (AP) - The European Union's drug regulator says it has started a rolling review of China's Sinovac coronavirus vaccine to assess its effectiveness and safety, a first step toward possible approval for use in the 27-nation bloc.
The European Medicines Agency said Tuesday that its decision to start the review is based on preliminary results from laboratory studies and clinical studies.
'œThese studies suggest that the vaccine triggers the production of antibodies'ť that fight the coronavirus 'œand may help protect against the disease,'ť the agency said in a statement.
The EMA added that no application has yet been submitted for marketing authorization for the vaccine.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.